Hualan Biological Engineering Inc. (SHE: 002007)
China
· Delayed Price · Currency is CNY
17.40
-0.11 (-0.63%)
Dec 27, 2024, 3:04 PM CST
Hualan Biological Engineering Revenue
Hualan Biological Engineering had revenue of 1.84B CNY in the quarter ending September 30, 2024, a decrease of -21.04%. This brings the company's revenue in the last twelve months to 4.92B, up 1.90% year-over-year. In the year 2023, Hualan Biological Engineering had annual revenue of 5.34B with 18.26% growth.
Revenue (ttm)
4.92B
Revenue Growth
+1.90%
P/S Ratio
5.97
Revenue / Employee
1.33M
Employees
3,709
Market Cap
29.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
Dec 31, 2019 | 3.70B | 483.04M | 15.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.93B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |